Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Neutral Lupin; target of Rs 2520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2520 in its research report dated May 10, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal is bullish on Five Star Business Finance has recommended buy rating on the stock with a target price of Rs 600 in its research report dated April 29, 2026.
Buy Granules India; target of Rs 820: Motilal Oswal
Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.
SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.